Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori is a Gram-negative, microaerophilic bacterium that colonizes the human gastric mucosa, leading to chronic inflammation and various gastrointestinal pathologies (StatPearls, 2023). The cell wall and membrane structures of H. pylori are critical for its survival in the acidic environment of the stomach, providing structural integrity and protection against osmotic stress (Journal of Bacteriology, 2010). These structures include a peptidoglycan layer, an inner cytoplasmic membrane, and an outer membrane containing lipopolysaccharides (LPS) and various outer membrane proteins (OMPs) that facilitate adhesion to gastric epithelial cells (Microbiology and Molecular Biology Reviews, 2003). Therapeutically, these structures are primary targets for antibiotics such as amoxicillin, which inhibits the synthesis of the peptidoglycan layer by binding to penicillin-binding proteins (PBPs) (PubChem). Bismuth-containing compounds also exert antimicrobial effects by disrupting the bacterial cell wall and cytoplasmic membrane (PubMed: PMID 10961714). Targeting these structural components is essential for the eradication of H. pylori infections, thereby reducing the risk of peptic ulcers and gastric cancer (World Journal of Gastroenterology, 2014). However, the increasing prevalence of antibiotic resistance targeting these pathways poses a significant challenge to successful treatment (Lancet Infectious Diseases, 2018). This target entry encompasses a broad range of molecular components rather than a single protein or receptor.
Inhibition of peptidoglycan cross-linking by binding to penicillin-binding proteins (PBPs) and direct disruption of the bacterial cell wall and membrane integrity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori cell wall and membrane structures.